INTERNATIONAL PATENT: BIONTECH SE, GENMAB A/S FILES APPLICATION FOR "METHODS OF TREATMENT USING AGENTS BINDING TO EPCAM AND CD137 IN COMBINATION WITH PD-1 AXIS BINDING ANTAGONISTS"

GENEVA, March 24 -- BIONTECH SE (An der Goldgrube 1255131 Mainz), GENMAB A/S (Carl Jacobsens Vej 302500 Valby) filed a patent application (PCT/EP2024/075677) for "METHODS OF TREATMENT USING AGENTS BINDING TO EPCAM AND CD137 IN COMBINATION WITH PD-1 AXIS BINDING ANTAGONISTS" on Sep 13, 2024. With publication no. WO/2025/056778, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAHIN, Ugur (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), FELLERMEIER-KOPF, Sina (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), IMLE, Andrea (c/o...